Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…

Creating a holistic direct to consumer (DTC) and healthcare provider (HCP) marketing strategy from scratch is a demanding task, especially if you don’t have the clinical expertise to precisely identify the consumers or providers you should be targeting. We’re here to give you 5 simple steps to creating a holistic DTC and HCP targeting strategy…

We are in the middle of an ongoing data-driven revolution in the pharmaceutical industry. Data and analytics are reshaping how companies approach sales and marketing strategies – and customer experience.

PurpleLab® provides a real-world data [lab], accelerating the discovery and adoption of healthcare innovations. View where PurpleLab insights have been leveraged.  Pharma Exec Balancing Personalized Targeting with Protecting Consumer Privacy Read Now 11/5/2024 Pharma Exec Promising Alternative Targeting Methods in a Post-Cookie World Read Now 11/4/2024 Pharma Exec Effectively Targeting Patients Without Cookies Read Now…

The value of real-world data (RWD) and real-world evidence (RWE) for pharmaceutical companies goes far beyond clinical and drug development applications, such as clinical trial feasibility studies, manufacturing, health economic and outcomes research and medical affairs. These datasets are also recognized as critical tools for shaping effective marketing and commercial strategies. The importance of real-world…

PurpleLab®, a leading healthcare analytics company with one of the largest medical and pharmaceutical claims databases in the US, is pleased to announce its membership in the Network Advertising Initiative (NAI), the leading self-regulatory organization dedicated to responsible data collection and use in digital advertising. In joining the NAI, PurpleLab strengthens its commitment to maintaining…

With celebrity endorsements of drugs from GLP-1s to migraine medications, pharmaceutical advertisers are embracing high-profile celebrity marketing. But in the age of social media, you don’t have to be a celebrity to have influence.

More than a year has passed since Humira biosimilars were launched in the US, and with these, several other biosimilar drug approvals that either directly compete with Humira or are indicated for other rare immunologic conditions, macular degeneration, and oncology and hematological disease.  Ongoing industry surveillance of biosimilars and the   Source: “Biosimilars are becoming more widely available,…

Learn more about what PurpleLab can do for Commercial Pharma Life Sciences Download

With celebrity endorsements of drugs from GLP-1s to migraine medications, pharmaceutical advertisers are embracing high-profile celebrity marketing. But in the age of social media, you don’t have to be a celebrity to have influence.

We provide a real-world data lab to accelerate the discovery and adoption of healthcare innovations. From life science companies, hospitals and health plans to agencies and advertising technology companies, PurpleLab is your trusted real-world-data partner.  Life Sciences Download Let’s Talk! Previous Next